Department of Otolaryngology Head and Neck Surgery, Nantes University Hospital, Nantes, France.
Nantes Université, CHU Nantes, Pôle Hospitalo-Universitaire 11: Santé Publique, Clinique des données, INSERM, CIC 1413, Nantes, France.
Cancer Med. 2024 Apr;13(7):e7031. doi: 10.1002/cam4.7031.
Transoral robotic surgery (TORS) opens new perspectives. We evaluated the outcomes for patients having undergone TORS after previous radiotherapy.
A retrospective multicenter study (n = 138) in a previously irradiated area between 2009 and 2020. Survival was assessed with the Kaplan-Meier method. Prognostic factors were evaluated using a chi-squared test, Fisher's test, or Wilcoxon's test.
The median length of hospital stay was 12.5 days. Bleeding was the most frequent postoperative complication (15.2%, n = 22). Prophylactic vessel ligation did not significantly decrease bleeding. Complications were significantly lower for Tis, T1, and N0 tumors. 91.6% (n = 120) of the patients with a perioperative tracheotomy could be decannulated. Larynx was functional for 65.94% of the patients. The median length of follow-up was 26 months. The 5-year overall and relapse-free survival rates were respectively 59.9% and 43.4%.
Oncological and functional results confirmed the value of TORS as a treatment in previously irradiated area.
经口机器人手术(TORS)开辟了新的视角。我们评估了先前接受过放射治疗的患者接受 TORS 后的结果。
这是一项 2009 年至 2020 年间在先前照射区域进行的回顾性多中心研究(n=138)。使用 Kaplan-Meier 方法评估生存率。使用卡方检验、Fisher 检验或 Wilcoxon 检验评估预后因素。
中位住院时间为 12.5 天。出血是最常见的术后并发症(15.2%,n=22)。预防性血管结扎并不能显著减少出血。Tis、T1 和 N0 肿瘤的并发症明显较低。有围手术期气管切开术的 91.6%(n=120)的患者可以拔管。65.94%的患者的喉部功能正常。中位随访时间为 26 个月。5 年总生存率和无复发生存率分别为 59.9%和 43.4%。
肿瘤学和功能学结果证实了 TORS 在先前照射区域作为治疗方法的价值。